A lyophilized sterically stabilized liposome-containing docetaxel: in vitro and in vivo evaluation

References

• Baker J, Ajani J, Scotte F, et al. (2009). Docetaxel-related side effects and their management. Eur J Oncol Nurs 13:49–59
   PubMed Web of Science ®Google Scholar
• Bhadra D, Bhadra S, Jain P, Jain NK. (2002). Pegnology: a review of PEG-ylated systems. Pharmazie 57:5–29
   PubMed Web of Science ®Google Scholar
• Chaudhury A, Das S, Lee RF, et al. (2012). Lyophilization of cholesterol-free PEGylated liposomes and its impact on drug loading by passive equilibration. Int J Pharm 430:167–75
   PubMed Web of Science ®Google Scholar
• Cortes JE, Pazdur R. (1995). Docetaxel. J Clin Oncol 13:2643–55
   PubMed Web of Science ®Google Scholar
• Crosasso P, Ceruti M, Brusa P, et al. (2000). Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. J Control Release 63:19–30
   PubMed Web of Science ®Google Scholar
• Diaz JF, Andreu JM. (1993). Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: reversibility, ligand stoichiometry, and competition. Biochemistry 32:2747–55
   PubMed Web of Science ®Google Scholar
• Engels FK, Sparreboom A, Mathot RAA, Verweij J. (2005). Potential for improvement of docetaxel-based chemotherapy: a pharmacological review. Br J Cancer 93:173–7
   PubMed Web of Science ®Google Scholar
• Gelmon K. (1994). The taxoids: paclitaxel and docetaxel. Lancet 344:1267–72
   PubMed Web of Science ®Google Scholar
• Guo BH, Cheng Y, Lin LP, et al. (2011). Preparation and characterization of galactose-modified liposomes by a nonaqueous enzymatic reaction. J Liposome Res 21:255–60
   PubMed Web of Science ®Google Scholar
• Guo W, Johnson JL, Khan S, et al. (2005). Paclitaxel quantification in mouse plasma and tissues containing liposome-entrapped paclitaxel by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetics study. Anal Biochem 336:213–20
   PubMed Web of Science ®Google Scholar
• Hinrichs WLJ, Manceñido FA, Sanders NN, et al. (2006). The choice of a suitable oligosaccharide to prevent aggregation of PEGylated nanoparticles during freeze thawing and freeze drying. Int J Pharm 311:237–44
   PubMed Web of Science ®Google Scholar
• Immordino ML, Brusa P, Arpicco S, et al. (2003). Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel. J Control Release 91:417–29
   PubMed Web of Science ®Google Scholar
• Kintzel PE, Pharm D, Laura B, et al. (2006). Docetaxel-associated epiphora. Pharmacotherapy 26:853–867
   PubMed Web of Science ®Google Scholar
• Kuyukina MS, Ivshina IB, Philp JC, et al. (2001). Recovery of Rhodococcus biosurfactants using methyl tertiary-butyl ether extraction. J Microbiol Methods 46:149–56
   PubMed Web of Science ®Google Scholar
• Li J, Xu H, Ke X, Tian J. (2012). The anti-tumor performance of docetaxel liposomes surface-modified with glycyrrhetinic acid. J Drug Target 20:467–73
   PubMed Web of Science ®Google Scholar
• Li Y, Zheng X, Sun Y, et al. (2014). RGD-fatty alcohol-modified docetaxel liposomes improve tumor selectivity in vivo. Int J Pharm 468:133–41
   PubMed Web of Science ®Google Scholar
• Luo LH, Zheng P, Nie H, et al. 2014. Pharmacokinetics and tissue distribution of docetaxel liposome mediated by a novel galactosylated cholesterol derivatives synthesized by lipase-catalyzed esterification in non-aqueous phase. Drug Deliv. [Epub ahead of print]. doi: 10.3109/10717544.2014.980525
   PubMed Web of Science ®Google Scholar
• Mortier KA, Renard V, Verstraete AG, et al. (2005). Development and validation of a liquid chromatography-tandem mass spectrometry assay for the quantification of docetaxel and paclitaxel in human plasma and oral fluid. Anal Chem 77:4677–83
   PubMed Web of Science ®Google Scholar
• Musumeci T, Ventura CA, Giannone I, et al. (2006). PLA/PLGA nanoparticles for sustained release of docetaxel. Int J Pharm 325:172–9
   PubMed Web of Science ®Google Scholar
• Ogris M, Walker G, Blessing T, et al. (2003). Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes. J Control Rel 91:173–81
   PubMed Web of Science ®Google Scholar
• Ringel I, Horwitz SB. (1991). Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol. J Natl Cancer Inst 83:288–91
   PubMed Web of Science ®Google Scholar
• Sadzuka Y, Nakade A, Hirama R, et al. (2002). Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome. Int J Pharm 238:171–80
   PubMed Web of Science ®Google Scholar
• Schnyder A, Huwyler JRg. (2005). Drug transport to brain with targeted liposomes. Neurotherapeutics 2:99–107
   Google Scholar
• Schwarz C, Mehnert W. (1997). Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN). Int J Pharm 157:171–9
   PubMed Web of Science ®Google Scholar
• Senior J, Gregoriadis G. (1982). Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components. Life Sci 30:2123–2136
   PubMed Web of Science ®Google Scholar
• Shehata T, Ogawara KI, Higaki K, Kimura T. (2008). Prolongation of residence time of liposome by surface-modification with mixture of hydrophilic polymers. Int J Pharm 359:272–9
   PubMed Web of Science ®Google Scholar
• Shi J, Zhang JL, Shen Y, et al. (2015). Arginine-stabilized mPEG-PDLLA (50/50) polymeric micelles of docetaxel by electrostatic mechanism for tumor-targeted delivery. Drug Deliv 22:168–81
   PubMed Web of Science ®Google Scholar
• Swaminathan J, Ehrhardt C. (2014). Effect of lyophilization on liposomal encapsulation of salmon calcitonin. J Liposome Res 24:297–303
   PubMed Web of Science ®Google Scholar
• Torchilin VP, Trubetskoy VS. (1995). Which polymers can make nanoparticulate drug carriers long-circulating? Adv Drug Deliv Rev 16:141–55
   Web of Science ®Google Scholar
• Van Winden ECA. (2003). Freeze-drying of liposomes: theory and practice. Meth Enzymol 367:99–110
   PubMed Web of Science ®Google Scholar
• Van Zuylen L, Verweij J, Sparreboom A. (2001). Role of formulation vehicles in taxane pharmacology. Invest New Drugs 19:125–41
   PubMed Web of Science ®Google Scholar
• Wang DK, Zhang CX, Zhang WT, et al. (2008). Characteristics and pharmacokinetics of docetaxel liposome containing Tween 80 or PEG-DSPE. J Drug Deliv Sci Technol 18:253–7
   Web of Science ®Google Scholar
• Wang X, Song L, Li N, et al. (2013). Pharmacokinetics and biodistribution study of paclitaxel liposome in Sprague-Dawley rats and Beagle dogs by liquid chromatography-tandem mass spectrometry. Drug Res (Stuttg) 63:603–6
   PubMedGoogle Scholar
• Yamaguchi H, Fujikawa A, Ito H, et al. (2012). A rapid and sensitive LC/ESI-MS/MS method for quantitative analysis of docetaxel in human plasma and its application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 893894:157–61
   Web of Science ®Google Scholar
• Yang T, Cui FD, Choi MK, et al. (2007). Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation. Int J Pharm 338:317–26
   PubMed Web of Science ®Google Scholar
• Yoshizawa Y, Kono Y, Ogawara K, et al. (2011). PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy. Int J Pharm 412:132–41
   PubMed Web of Science ®Google Scholar
• Yuan Z, Chen D, Zhang S, Zheng Z. (2010). Preparation, characterization and evaluation of docetaxel-loaded, folate-conjugated PEG-liposomes. Yakugaku Zasshi 130:1353–9
   PubMed Web of Science ®Google Scholar
• Zhang H, Li RY, Lu X, et al. (2012). Docetaxel-loaded liposomes: preparation, pH sensitivity, pharmacokinetics, and tissue distribution. J Zhejiang Univ Sci B 13:981–9
   PubMed Web of Science ®Google Scholar
• Zhao MM, Su M, Lin X, et al. (2010). Evaluation of docetaxel-loaded intravenous lipid emulsion: pharmacokinetics, tissue distribution, antitumor activity, safety and toxicity. Pharmaceutical Res 27:1687–1702
   PubMed Web of Science ®Google Scholar